Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies

Schildknecht, Stefan, Gerding, Hanne R., Karreman, Christiaan, Drescher, Malte, Lashuel, Hilal A., Outeiro, Tiago F., Di Monte, Donato A., Leist, Marcel·2013·Journal of Neurochemistry
DOI 10.1111/jnc.12226

Cited by (148)

Items 101–148 of 148

  1. The future of Parkinson’s disease research: A new paradigm of human-specific investigation is necessary… and possible
    Manuela Cassotta · 2022 · ALTEX
  2. The N-Terminal Residues 43 to 60 Form the Interface for Dopamine Mediated α-Synuclein Dimerisation
    Su Ling Leong, Mark G. Hinds, Andrea R. Connor, David P. Smith, Eva Illes‐Toth, Chi L.L. Pham, Kevin Jeffrey Barnham, Roberto Cappai · 2015 · PLoS ONE
  3. NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients
    Vanessa Porrini, Andrea Pilotto, Marika Vezzoli, Annamaria Lanzillotta, Michele Mario Gennari, Sonia Bonacina, Antonella Alberici, Rosanna Turrone, Arianna Bellucci, Angelo Antonini et al. · 2023 · Neurobiology of Disease
  4. A Novel Bibenzyl Compound (20C) Protects Mice from 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine/Probenecid Toxicity by Regulating the α-Synuclein–Related Inflammatory Response
    Qiu-Shuang Zhang, Yang Heng, Ying Chen, Piao Luo, Lu Wen, Zhao Zhang, Yu‐He Yuan, Nai‐Hong Chen · 2017 · Journal of Pharmacology and Experimental Therapeutics
  5. Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates
    Xiaodi Guo, Jie Xiang, Keqiang Ye, Zhentao Zhang · 2025 · Cells
  6. Novel pathophysiological roles of α‐synuclein in age‐related vascular endothelial dysfunction
    Yoichi Takami, Cheng Wang, Hironori Nakagami A, Koichi I. Yamamoto, Yoichi Nozato, Yuki Imaizumi, Motonori Nagasawa, Hikari Takeshita, Tsuneo Nakajima, Shuko Takeda et al. · 2022 · The FASEB Journal
  7. Neurodegenerative Aspects of Multiple System Atrophy
    Rowan A. W. Radford, Mathew B. Wong, Dean L. Pountney · 2014 · Springer eBooks
  8. Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α‐Synuclein
    Jon W. Werner‐Allen, Jenna F. DuMond, Rodney L. Levine, Ad Bax · 2016 · Angewandte Chemie
  9. Oxime blot: A novel method for reliable and sensitive detection of carbonylated proteins in diverse biological systems
    Romain Ladouce, Guillaume Fabien Combes, Katarina Trajković, Irena Drmić Hofman, Mladen Merćep · 2023 · Redox Biology
  10. Formation of 2-nitrophenol from salicylaldehyde as a suitable test for low peroxynitrite fluxes
    Yuliya Mikhed, Kai Bruns, Stefan Schildknecht, Michael Jörg, Mobin Dib, Matthias Walter Oelze, Karl Johannes Lackner, Thomas F. Münzel, Volker Ullrich, Andreas Daiber · 2015 · Redox Biology
  11. The role of type 2 Diabetes mellitus as a risk factor for Alzheimer's and Parkinson's diseases
    Kellen Mariane Athaide Rocha, Aline da Silva Goulart, Márcio Tavares Costa, Andréia Caroline Fernandes Salgueiro, Vanderlei Folmer · 2021 · Research Society and Development
  12. Sources of Oxidative Stress in Parkinson’s Disease: Pathways and Therapeutic Implications
    Yordan Yordanov, Denitsa Stefanova, Magdalena Kondeva-Burdina, Virginia Tzankova · 2026 · Antioxidants
  13. Megadalton-sized Dityrosine Aggregates of α-Synuclein Retain High Degrees of Structural Disorder and Internal Dynamics
    Silvia Verzini, Maliha Shah, François‐Xavier Theillet, Adam Belsom, Jan Bieschke, Erich E. Wanker, Juri Rappsilber, Andrés Binolfi, Philipp Selenko · 2020 · Journal of Molecular Biology
  14. Pt( iv ) complex selectively oxidizes alpha-synuclein methionine as disclosed by NMR
    Bin-Bin Pan, Huizhong Liu, Wei‐Han Meng, Xun‐Cheng Su · 2022 · Inorganic Chemistry Frontiers
  15. Parkinson’s Disease: Basic Pathomechanisms and a Clinical Overview
    Alastair John Noyce, Rina Bandopadhyay · 2017 · Advances in neurobiology
  16. A Red-Emitting Fluorescent Probe for Visualizing Hydroxyl Radical in Parkinson’s Disease and Guiding the Discovery of Methyl Ferulate for Therapeutic Intervention
    Hanbing Zheng, Shunping Zang, Hankun Zhang, Ao Li, Benhua Wang, Kefu Liu, Minhuan Lan, Xiangzhi Song · 2025 · Analytical Chemistry
  17. Environmental pollutants and alpha-synuclein toxicity in Parkinson’s disease
    Sudhamoy Roy, Violina Kakoty, Amirhossein Sahebkar, Shadab Md, Prashant Kesharwani · 2024 · Pathology - Research and Practice
  18. Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study
    Yan Wang, Peng-Peng Gao, Zicong Wu, Bing Jiang, Yanru Wang, Zhaxicao He, Bing Zhao, Xinyun Tian, Han Gao, Li Cai et al. · 2024 · Journal of Ethnopharmacology
  19. Profiling Dopamine-Induced Oxidized Proteoforms of β-synuclein by Top-Down Mass Spectrometry
    Arianna Luise, Elena De Cecco, Erika Ponzini, Martina Sollazzo, Pierluigi Mauri, Frank Sobott, Giuseppe Legname, Rita Grandori, Carlo Santambrogio · 2021 · Antioxidants
  20. Oxidative stress induced by sustained supraphysiological intrastriatal GDNF delivery is prevented by dose regulation
    Marcelo Duarte Azevedo, Naika Prince, Marie Humbert‐Claude, Virginia Mesa-Infante, Cheryl Jeanneret, Valentine Golzné, Kevin De Matos, Benjamin Boury Jamot, Fulvio Magara, Tomás González‐Hernández et al. · 2023 · Molecular Therapy — Methods & Clinical Development
  21. Anti-Oxidants, the Aging Brain and Age-Related Brain Disorders
    Michel Baudry, Bernard Malfroy-Camine · 2016 · Oxidative stress in applied basic research and clinical practice
  22. Role of cellular oxidative stress in dementia
    Giovanna Galliciotti, Antonella De Jaco, Diego Sepúlveda Falla, Emanuela D’Acunto, Elena Miranda · 2020 · Elsevier eBooks
  23. Oxidative Stress and Neurodegeneration
    Newman Osafo, David Darko Obiri, Kwabena Owusu Danquah, Kofi Oduro Yeboah, Aaron Opoku Antwi, Mahmood Brobbey Oppong · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  24. Neurodegenerative Aspects of Multiple System Atrophy
    Rowan A. W. Radford, Mathew B. Wong, Dean L. Pountney · 2022 · Springer eBooks
  25. Specific detection of protein carbonylation sites by 473 nm photodissociation mass spectrometry
    Romain Ladouce, Luke MacAleese, Karlo Wittine, Mladen Merćep, Marion Girod · 2023 · Analytical and Bioanalytical Chemistry
  26. Tyrosine Nitroxidation Does Not Affect the Ability of α-Synuclein to Bind Anionic Micelles, but It Diminishes Its Ability to Bind and Assemble Synaptic-like Vesicles
    Ana Belén Uceda, Juan Frau, Bartolomé Vilanova, Miquel Adrover · 2023 · Antioxidants
  27. Formalization and Simulation of alpha-Synuclein Aggregation and Propagation under Different Pathobiological Conditions in PSMaude
    Lucian Bentea, Peter Csaba Ölveczky, Eduard Bentea · 2014 · NORA - Norwegian Open Research Archives
  28. Mechanisms of Toxicity
    Swati Betharia, Fred F. Farris, George B. Corcoran, Sidhartha D. Ray · 2014 · Elsevier eBooks
  29. An appraisal on biomolecular imaging in diagnosis of neurological disorders and innovation in clinical research
    Deepti Katiyar, Manish Manish · 2025 · Letters in Drug Design & Discovery
  30. Aggregation and conformation of alpha-synuclein: effects of ligand binding and phosphomimetics
    Aimee R. Paskins · 2017 · Sheffield Hallam University
  31. Molecular hydrogen inhalation prevents L-DOPA-induced dyskinesia in a Parkinson's disease rat model
    Glauce Crivelaro Nascimento, Elaine Del Bel · 2022
  32. Enfermedad de Parkinson: Modificaciones oxidativas y su rol en la toxicidad de α-sinucleína
    Ezequiel Giménez · 2022 · El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
  33. Design and Synthesis of New Non-Antibiotic Doxycyclin Derivatives Against alpha-Synuclein Aggregation with Anti-Inflammatory Properties
    Clémence Rose, Laurent Ferrié, Rodrigo Hernán Tomas‐Grau, Brenda Zabala, Jean Michel Brunel, Patrick Pierre Michel, Rosana Nieves Chehín, Rita Raisman‐Vozari, Bruno Figadère · 2023 · ChemRxiv
  34. Etablierung von LUHMES als Zellmodell menschlicher Dopamin-Neurone
    Stefan Schildknecht · 2014 · BIOspektrum
  35. C-terminal tyrosine residue modifications modulate α-synuclein toxicity in yeast as unicellular model for Parkinson´s disease
    Alexandra Kleinknecht · 2016
  36. Protein Oxidation, Quality-Control Mechanisms and Parkinson’s Disease
    Pablo Hernández-Franco, Annadurai Anandhan, Rodrigo Franco · 2017 · Royal Society of Chemistry eBooks
  37. Endoplasmic Reticulum Stress is Transmissible among Cells of the Central Nervous System
    Neil T. Sprenkle · 2017
  38. The Environmental Contribution to Redox Dyshomeostasis in Parkinson’s Disease
    Carla Garza-Lombó, Rodrigo Franco · 2022 · Molecular and integrative toxicology
  39. Nutrition in Brain Aging: Its Relevance to Age-Associated Neurodegeneration
    Wakako Maruyama, Masayo Shamoto‐Nagai, Makoto Naoi · 2022 · Springer eBooks
  40. Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies_suppl
    Markus Brüll · 2020 · ALTEX
  41. Nutrition in Brain Aging: Its Relevance to Age-Associated Neurodegeneration
    Wakako Maruyama, Masayo Shamoto Nagai, Makoto Naoi · 2022 · Springer eBooks
  42. Reduced levels of nitrated α-synuclein in the protective effect of harpagoside on rotenone-induced cellular models of Parkinson’s disease
    Juan Lang, Zhongkui Xiong · 2025 · Frontiers in Cell and Developmental Biology
  43. Mechanisms of Cognitive Aging: Health and Pathology
    Valentina F. Kitchigina · 2026 · Neuroscience and Behavioral Physiology
  44. Rôles de FOXO3 dans la réponse cellulaire au stress et la neurodégénérescence au cours de la maladie Parkinson
    Baptiste Texier · 2024 · theses.fr (ABES)
  45. Characterization and quantification of proteins involved in neurodegenerative diseases by mass spectrometry
    Kim Thanh Van · 2025 · theses.fr (ABES)
  46. Antibody treatment targeting nitrated alpha-synuclein counteracts protein spreading pathology
    Ayşe Ulusoy, Sarah Wright, Pietro La Vitola, Katharina Klinger, Eugenia L. Harbachova, Angela Rollar, Xiang Xu, Anushka Takhi, Nathan Behrendt, Anthony Mastracci et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Glutathione Biology in Neurodegenerative and Metabolic Diseases: Molecular Mechanisms, Pathophysiological Roles, and Therapeutic Perspectives
    Grażyna Gromadzka, Magdalena Kąkol, Magdalena Klimkiewicz, Maria Bendykowska · 2026 · International Journal of Molecular Sciences
  48. Targeting α-Synuclein as a Parkinson’s Disease Therapeutic
    Luke Esposito · 2014 · Topics in medicinal chemistry